Group 2 for Parasomnias

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Parasomnias+3 More
melatonin 6mg - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty.

Eligible Conditions
  • Parasomnias
  • Sleep Disturbance
  • Arthroplasty

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 weeks

6 weeks
Patient Sleep Quality

Trial Safety

Trial Design

2 Treatment Groups

Group 2
1 of 2
Group 1
1 of 2
Active Control
Non-Treatment Group

154 Total Participants · 2 Treatment Groups

Primary Treatment: Group 2 · Has Placebo Group · N/A

Group 2
Drug
ActiveComparator Group · 1 Intervention: melatonin 6mg · Intervention Types: Drug
Group 1
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 weeks

Who is running the clinical trial?

Rothman Institute OrthopaedicsLead Sponsor
112 Previous Clinical Trials
19,959 Total Patients Enrolled
1 Trials studying Parasomnias
80 Patients Enrolled for Parasomnias

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: October 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.